• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌少性肥胖:一个新出现的公共卫生问题。

Sarcopenic Obesity: An Emerging Public Health Problem.

作者信息

Ji Tong, Li Yun, Ma Lina

机构信息

Department of Geriatrics, Xuanwu Hospital, Capital Medical University, National Research Center for Geriatric Medicine, Beijing 100053, China.

出版信息

Aging Dis. 2022 Apr 1;13(2):379-388. doi: 10.14336/AD.2021.1006. eCollection 2022 Apr.

DOI:10.14336/AD.2021.1006
PMID:35371597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8947824/
Abstract

Population aging and the obesity epidemic are important global public health problems that pose an unprecedented threat to the physical and mental health of the elderly and health systems worldwide. Sarcopenic obesity (SO) is a new category of obesity and a high-risk geriatric syndrome in the elderly. SO is associated with many adverse health consequences such as frailty, falls, disability, and increased morbidity and mortality. The core mechanism of SO is the vicious circle between myocytes and adipocytes. In order to implement effective prevention and treatment strategies and reduce adverse clinical outcomes, it is essential to further our understanding of SO in the elderly. Herein, we reviewed the definition, diagnosis, epidemiology, pathogenesis, and treatment of SO in older adults.

摘要

人口老龄化和肥胖流行是重要的全球公共卫生问题,对全球老年人的身心健康及卫生系统构成了前所未有的威胁。肌少症性肥胖(SO)是肥胖的一种新类型,也是老年人中的一种高危老年综合征。SO与许多不良健康后果相关,如身体虚弱、跌倒、残疾以及发病率和死亡率增加。SO的核心机制是肌细胞和脂肪细胞之间的恶性循环。为了实施有效的预防和治疗策略并减少不良临床结局,进一步了解老年人的SO至关重要。在此,我们综述了老年人SO的定义、诊断、流行病学、发病机制和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee0/8947824/251bcdd33dc3/AD-13-2-379-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee0/8947824/251bcdd33dc3/AD-13-2-379-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fee0/8947824/251bcdd33dc3/AD-13-2-379-g1.jpg

相似文献

1
Sarcopenic Obesity: An Emerging Public Health Problem.肌少性肥胖:一个新出现的公共卫生问题。
Aging Dis. 2022 Apr 1;13(2):379-388. doi: 10.14336/AD.2021.1006. eCollection 2022 Apr.
2
Longitudinal associations between body composition, sarcopenic obesity and outcomes of frailty, disability, institutionalisation and mortality in community-dwelling older men: The Concord Health and Ageing in Men Project.社区居住的老年男性中,身体成分、肌少症性肥胖与虚弱、残疾、住院和死亡结局之间的纵向关联:康科德健康与老龄化男性研究。
Age Ageing. 2017 May 1;46(3):413-420. doi: 10.1093/ageing/afw214.
3
Sarcopenic obesity: Time to meet the challenge.肌少症性肥胖:是时候迎接挑战了。
Clin Nutr. 2018 Dec;37(6 Pt A):1787-1793. doi: 10.1016/j.clnu.2018.04.018. Epub 2018 May 7.
4
Common and different characteristics among combinations of physical frailty and sarcopenia in community-dwelling older adults: The Korean Frailty and Aging Cohort Study.社区居住老年人身体虚弱与肌肉减少症组合之间的共同和不同特征:韩国虚弱与衰老队列研究。
Geriatr Gerontol Int. 2022 Jan;22(1):42-49. doi: 10.1111/ggi.14314. Epub 2021 Nov 23.
5
Sarcopenic Obesity: Time to Meet the Challenge.肌少症性肥胖:是时候迎接挑战了。
Obes Facts. 2018;11(4):294-305. doi: 10.1159/000490361. Epub 2018 Jul 18.
6
Screening for Frailty and Sarcopenia Among Older Persons in Medical Outpatient Clinics and its Associations With Healthcare Burden.在医疗门诊中筛查老年人虚弱和肌少症及其与医疗负担的关系。
J Am Med Dir Assoc. 2017 Jul 1;18(7):583-587. doi: 10.1016/j.jamda.2017.01.004. Epub 2017 Feb 24.
7
Health consequences of obesity in the elderly: a review of four unresolved questions.老年人肥胖的健康后果:四个未解决问题的综述
Int J Obes (Lond). 2005 Sep;29(9):1011-29. doi: 10.1038/sj.ijo.0803005.
8
Sarcopenic obesity.肌少症性肥胖。
Hormones (Athens). 2018 Sep;17(3):321-331. doi: 10.1007/s42000-018-0049-x. Epub 2018 Jul 16.
9
Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity.肌肉流失与肥胖:肌少症和肌少症肥胖对健康的影响。
Proc Nutr Soc. 2015 Nov;74(4):405-12. doi: 10.1017/S002966511500169X. Epub 2015 Apr 27.
10
Sarcopenia and sarcopenic obesity.肌肉减少症和肌肉减少性肥胖症。
Korean J Intern Med. 2016 Nov;31(6):1054-1060. doi: 10.3904/kjim.2016.193. Epub 2016 Nov 1.

引用本文的文献

1
The Impact of Sarcopenic Obesity on Frailty, Cognition, and Function in Community-Dwelling Older Adults.肌少性肥胖对社区居住老年人衰弱、认知和功能的影响。
J Frailty Sarcopenia Falls. 2025 Sep 1;10(3):150-156. doi: 10.22540/JFSF-10-150. eCollection 2025 Sep.
2
Relationship between triglyceride-glucose index and all-cause mortality in older adults with sarcopenic obesity.肌少性肥胖老年人中甘油三酯-葡萄糖指数与全因死亡率的关系。
Metabol Open. 2025 Aug 24;27:100388. doi: 10.1016/j.metop.2025.100388. eCollection 2025 Sep.
3
The Role of Rehabilitation Program in Managing the Triad of Sarcopenia, Obesity, and Chronic Pain.

本文引用的文献

1
Global prevalence of sarcopenic obesity in older adults: A systematic review and meta-analysis.全球老年人肌少症性肥胖的患病率:系统评价和荟萃分析。
Clin Nutr. 2021 Jul;40(7):4633-4641. doi: 10.1016/j.clnu.2021.06.009. Epub 2021 Jun 21.
2
Sarcopenic obesity and its association with respiratory disease incidence and mortality - Authors' reply.肌少性肥胖及其与呼吸系统疾病发病率和死亡率的关联——作者回复
Clin Nutr. 2021 May;40(5):2520. doi: 10.1016/j.clnu.2021.03.030. Epub 2021 Mar 31.
3
The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications.
康复计划在管理肌肉减少症、肥胖症和慢性疼痛三联征中的作用。
Life (Basel). 2025 Jul 24;15(8):1174. doi: 10.3390/life15081174.
4
Prevalence and risk of metabolic dysfunction-associated steatotic liver disease in patients with sarcopenic obesity: a systematic review and meta-analysis.肌肉减少性肥胖患者中代谢功能障碍相关脂肪性肝病的患病率和风险:一项系统评价和荟萃分析
Nutr Metab (Lond). 2025 Aug 27;22(1):101. doi: 10.1186/s12986-025-01000-4.
5
The impact of elevated dietary inflammatory potential on sarcopenic obesity: evidence from two observational studies.饮食炎症潜能升高对肌少症肥胖的影响:两项观察性研究的证据。
Front Nutr. 2025 Aug 11;12:1621199. doi: 10.3389/fnut.2025.1621199. eCollection 2025.
6
Prevalence of Sarcopenic Obesity in Elderly Population: A Meta-Analysis.老年人群中肌少性肥胖的患病率:一项荟萃分析。
Curr Aging Sci. 2025;18(2):147-162. doi: 10.2174/0118746098331277241101025928.
7
Sarcopenic obesity in the Asia-Pacific region: Epidemiology, risk factors, and management.亚太地区的肌少症性肥胖:流行病学、危险因素及管理
Osteoporos Sarcopenia. 2025 Jun;11(2 Suppl):40-49. doi: 10.1016/j.afos.2025.05.001. Epub 2025 May 21.
8
Nutrition and Aging Biology: Summary of a Research Centers Collaborative Network Workshop and Research Needs.营养与衰老生物学:研究中心协作网络研讨会总结及研究需求
Curr Dev Nutr. 2025 Jun 18;9(7):107485. doi: 10.1016/j.cdnut.2025.107485. eCollection 2025 Jul.
9
Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and Sarcopenic obesity in U.S. adults: a cross-sectional study.美国成年人非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值与肌少症肥胖之间的关联:一项横断面研究
Prev Med Rep. 2025 Jun 26;56:103151. doi: 10.1016/j.pmedr.2025.103151. eCollection 2025 Aug.
10
Association of sarcopenic obesity with cognitive dysfunction: A systematic review and meta-analysis.肌少性肥胖与认知功能障碍的关联:一项系统综述和荟萃分析。
Neurosciences (Riyadh). 2025 Jul;30(3):177-188. doi: 10.17712/nsj.2025.3.20240131.
肌肉减少性肥胖在癌症和心血管疾病中的作用:病理生理方面和临床意义证据的综合。
Int J Mol Sci. 2021 Apr 21;22(9):4339. doi: 10.3390/ijms22094339.
4
Therapeutic strategies for sarcopenic obesity: a systematic review.肥胖型肌少症的治疗策略:一项系统综述
Curr Opin Clin Nutr Metab Care. 2021 Jan;24(1):33-41. doi: 10.1097/MCO.0000000000000714.
5
Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments.糖尿病与肌少症性肥胖:发病机制、诊断与治疗。
Front Endocrinol (Lausanne). 2020 Aug 25;11:568. doi: 10.3389/fendo.2020.00568. eCollection 2020.
6
Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective.老年人肌少症合并肥胖的蛋白质摄入影响:肠道微生物组学视角。
Nutrients. 2020 Jul 30;12(8):2285. doi: 10.3390/nu12082285.
7
Sarcopenic obesity: Myokines as potential diagnostic biomarkers and therapeutic targets?肌少症性肥胖:肌肉因子作为潜在的诊断生物标志物和治疗靶点?
Exp Gerontol. 2020 Oct 1;139:111022. doi: 10.1016/j.exger.2020.111022. Epub 2020 Jul 21.
8
Inflammation and metabolism: the role of adiposity in sarcopenic obesity.炎症与代谢:肥胖在肌少性肥胖中的作用
Proc Nutr Soc. 2020 Jul 16:1-13. doi: 10.1017/S0029665120007119.
9
Sarcopenic obesity in ageing: cardiovascular outcomes and mortality.衰老相关的肌少症性肥胖:心血管结局和死亡率。
Br J Nutr. 2020 Nov 28;124(10):1102-1113. doi: 10.1017/S0007114520002172. Epub 2020 Jun 18.
10
Adenosine/A2B Receptor Signaling Ameliorates the Effects of Aging and Counteracts Obesity.腺苷/A2B 受体信号转导可改善衰老的影响并对抗肥胖。
Cell Metab. 2020 Jul 7;32(1):56-70.e7. doi: 10.1016/j.cmet.2020.06.006. Epub 2020 Jun 25.